Quarterly report pursuant to Section 13 or 15(d)

Accounts Receivable and Concentration of Credit Risk

v3.19.1
Accounts Receivable and Concentration of Credit Risk
6 Months Ended
Mar. 31, 2019
Accounts Receivable and Concentration of Credit Risk [Abstract]  
Accounts Receivable and Concentration of Credit Risk

Note 4 – Accounts Receivable and Concentration of Credit Risk



The Company's standard credit terms vary from 30 to 120 days, depending on the class of trade and customary terms within a territory, so accounts receivable is affected by the mix of purchasers within the period.  As is typical in the Company's business, extended credit terms may occasionally be offered as a sales promotion or for certain sales.  The Company has agreed to credit terms of up to 150 days with our distributor in the Republic of South Africa.  For the order of 15 million units under the Brazil tender in 2014, the Company agreed to up to 360 days credit terms with our distributor in Brazil subject to earlier payment upon receipt of payment by the distributor from the Brazilian Government.   



The components of accounts receivable consist of the following at March 31, 2019 and September 30, 2018:  









 

 

 

 

 

 



 

March 31,
2019

 

September 30,
2018



 

 

 

 

 

 

Accounts receivable

 

$

4,076,745 

 

$

4,046,733 

Less: allowance for doubtful accounts

 

 

(36,201)

 

 

(36,201)

Less: allowance for sales and payment term discounts

 

 

(13,309)

 

 

(37,900)

Accounts receivable, net

 

$

4,027,235 

 

$

3,972,632 



On December 27, 2017, we entered into a settlement agreement with Semina, our distributor in Brazil, pursuant to which Semina made a payment of $2.2 million and was obligated to make a second payment of $1.5 million by February 28, 2018, to settle net amounts due to us totaling $7.5 million relating to the Brazil tender in 2014. The settlement was not related to our belief in the ultimate collectability of the receivables or in the creditworthiness of Semina. We elected to settle these amounts due to the uncertainty regarding the timing of payment by the Brazilian Government and, ultimately to us, on the remaining amounts due. The result of the settlement was a net loss of $3.8 million in the six months ended March 31, 2018, which is presented as a separate line item in the accompanying unaudited condensed consolidated statements of operations. Semina did not make its second payment of $1.5 million by February 28, 2018.  In July 2018, the Company agreed to accept $1.3 million as settlement of the $1.5 million that was owed, which resulted in an additional loss of $0.2 million in the third quarter of fiscal 2018



At March 31, 2019, one customer had an accounts receivable balance that represented 11% of current assets.  At September 30, 2018, one customer had an accounts receivable balance that represented 15% of current assets.



At March 31, 2019, two customers had an accounts receivable balance greater than 10% of net accounts receivable, representing 65% of net accounts receivable in the aggregate. At September 30, 2018, three customers had an accounts receivable balance greater than 10% of net accounts receivable, representing 74% of net accounts receivable in the aggregate. 



For the three months ended March 31, 2019, there were four customers whose individual net revenue to the Company exceeded 10% of the Company’s net revenues, representing 82% of the Company’s net revenues in the aggregate. For the three months ended March 31, 2018, there were two customers whose individual net revenue to the Company exceeded 10% of the Company’s net revenues, representing 44% of the Company’s net revenues in the aggregate.



For the six months ended March 31, 2019, there were three customers whose individual net revenue to the Company exceeded 10% of the Company’s net revenues, representing 66% of the Company’s net revenues in the aggregate. For the six months ended March 31, 2018, there were three customers whose individual net revenue to the Company exceeded 10% of the Company’s net revenues, representing 50% of the Company’s net revenues in the aggregate.



The Company maintains an allowance for doubtful accounts for estimated losses resulting from the inability of its customers to make required payments on accounts receivable.  Management determines the allowance for doubtful accounts by identifying troubled accounts and by using historical experience applied to an aging of accounts.  Management also periodically evaluates individual customer receivables and considers a customer’s financial condition, credit history, and the current economic conditions.  Accounts receivable are charged-off when deemed uncollectible.  The table below summarizes the change in the allowance for doubtful accounts for the six months ended March 31, 2019 and 2018.







 

 

 

 

 



Six Months Ended March 31,



 

2019

 

 

2018



 

 

 

 

 

Beginning balance

$

36,201 

 

$

38,103 

Charges to expense

 

 —

 

 

3,058 

Charge-offs

 

 —

 

 

(5,000)

Ending balance

$

36,201 

 

$

36,161 



Recoveries of accounts receivable previously charged-off are recorded when received.  The Company’s customers are primarily large global agencies, non-government organizations, ministries of health and other governmental agencies,  which purchase and distribute FC2 for use in HIV/AIDS prevention and family planning programs. In the U.S., the Company’s customers include telemedicine providers who sell into the prescription channel.